Publications

5808 Results

Phase II trial of diaziquone in patients with refractory andrelapsing multiple myeloma: A Southwest Oncology Group Study.

Authors
WJ Stuckey;J Crowley;LH Baker;NR Larrimer;KH Hanson;JD Bonnet;LA White, Jr
Journal / Conference
Cancer Treat Rep 71(11):1095-1096
Year
1987
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8310

Cisplatin, vinblastine, and mitoguazone in squamous cell carcinomaof the esophagus: A Southwest Oncology Group Study.

Authors
R Chapman;TR Fleming;J Van Damme;J Macdonald
Journal / Conference
Cancer Treat Rep 71(12):1185-1187
Year
1987
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8311

Evaluation of fludarabine phosphate in renal cell carcinoma: ASouthwest Oncology Group study.

Authors
L Balducci;B Blumenstein;DD Von Hoff;M Davis;HE Hynes;RM Bukowski;ED Crawford
Journal / Conference
Cancer Treat Rep 71(5):543-544
Year
1987
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8316

Phase II study of fludarabine phosphate in previously untreatedpatients with hepatoma: A Southwest Oncology Group Study.

Authors
WH Harvey;TR Fleming;G Beltran;JH Saiers;N Oishi;DD Von Hoff
Journal / Conference
Cancer Treat Rep 71(11):1111-1112
Year
1987
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8318

Combined treatment with chemotherapy and neutron irradiation for limited non-small cell lung cancer: A Southwest Oncology Group study.

Authors
RB Livingston;BR Griffin;CS Higano;GE Laramore;SE Rivkin;RS Goldberg;SF Schulman
Journal / Conference
JCO 5(11):1716-1724
Year
1987
Research Committee(s)
Lung
Study Number(s)
SWOG-8367

Platinum analogs in recurrent and advanced head and neck cancer:A Southwest Oncology Group and Wayne State University Study.

Authors
M Al-Sarraf;B Metch;J Kish;J Ensley;JJ Rinehart;DE Schuller;C Coltman, Jr
Journal / Conference
Cancer Treat Rep 71(7-8):723-726
Year
1987
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8371

Phase II study of fludarabine phosphate in previously untreatedpatients with colorectal carcinoma: A Southwest Oncology Group study.

Authors
WH Harvey;TR Fleming;DD Von Hoff;JG Katterhagen;C Coltman, Jr
Journal / Conference
Cancer Treat Rep 71(12):1319-1320
Year
1987
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8386

Phase II trial of fludarabine phosphate in patients with head andneck cancer: A Southwest Oncology Group Study.

Authors
GB Weiss;B Metch;DD Von Hoff;SA Taylor;JH Saiers
Journal / Conference
Cancer Treat Rep 71(12):1313-1314
Year
1987
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8403

Southwest Oncology Group clinical trials for intermediate andhigh-grade non-hodgkin's lymphomas.

Authors
RI Fisher;TP Miller;BW Dana;SE Jones;S Dahlberg;C Coltman, Jr
Journal / Conference
Seminars in Hematology 24(2):21-25
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8410, SWOG-8503, SWOG-8508, SWOG-8516 (INT-0067)

Phase II evaluation of teniposide and ifosfamide in refractoryadult acute lymphocytic leukemia: A Southwest Oncology Group study.

Authors
DH Ryan;KJ Kopecky;D Head;CN Gumbart;MR Grever;C Karanes;JK Weick;C Coltman, Jr
Journal / Conference
Cancer Treat Rep 71(7-8):713-716
Year
1987
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8243, SWOG-8522